Header Logo

Ankeet Bhatt

Concepts (184)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
44
2023
396
16.530
Why?
Cardiovascular Diseases
8
2022
599
2.960
Why?
Stroke Volume
19
2023
100
2.840
Why?
Pandemics
9
2022
287
2.760
Why?
Humans
62
2023
17762
2.410
Why?
Influenza Vaccines
5
2023
273
2.210
Why?
Angiotensin Receptor Antagonists
7
2022
53
2.040
Why?
Hospitalization
14
2023
808
2.010
Why?
Influenza, Human
5
2023
265
1.830
Why?
Cardiology
3
2022
30
1.680
Why?
Coronavirus Infections
4
2020
49
1.660
Why?
Pneumonia, Viral
4
2020
56
1.650
Why?
Biphenyl Compounds
7
2022
10
1.340
Why?
Aminobutyrates
7
2022
18
1.330
Why?
Treatment Outcome
12
2022
1260
1.190
Why?
Drug Combinations
7
2022
41
1.190
Why?
Myocardial Infarction
2
2022
238
1.180
Why?
Ventricular Dysfunction, Left
3
2022
20
1.160
Why?
Valsartan
6
2022
11
1.140
Why?
Pneumococcal Vaccines
2
2018
66
1.120
Why?
Neprilysin
4
2022
10
0.970
Why?
Aged
16
2023
6150
0.920
Why?
Betacoronavirus
3
2020
35
0.910
Why?
Acute Coronary Syndrome
2
2020
18
0.900
Why?
Hospital Mortality
7
2022
145
0.830
Why?
Registries
6
2023
472
0.820
Why?
Cardiovascular System
1
2022
4
0.820
Why?
Vaccination
5
2023
655
0.820
Why?
Curriculum
1
2022
35
0.810
Why?
ST Elevation Myocardial Infarction
1
2022
6
0.800
Why?
Heart Diseases
2
2021
77
0.790
Why?
Acute Kidney Injury
1
2022
44
0.790
Why?
Tetrazoles
4
2022
15
0.760
Why?
Eye Diseases
1
2021
6
0.760
Why?
Medicine
1
2021
22
0.760
Why?
Enalapril
1
2021
8
0.760
Why?
Polypharmacy
1
2021
13
0.760
Why?
Patient Discharge
2
2021
154
0.750
Why?
International Classification of Diseases
1
2021
85
0.720
Why?
Adrenergic beta-Antagonists
2
2019
43
0.710
Why?
Pneumonia, Pneumococcal
2
2018
13
0.710
Why?
Male
17
2023
10106
0.670
Why?
United States
10
2022
4003
0.630
Why?
Evidence-Based Medicine
1
2020
186
0.610
Why?
Ventricular Remodeling
1
2017
6
0.580
Why?
Heart Rate
1
2017
41
0.560
Why?
Ventricular Function, Left
3
2023
51
0.560
Why?
Angiotensin-Converting Enzyme Inhibitors
4
2022
86
0.550
Why?
Leg Dermatoses
1
2016
1
0.550
Why?
Middle Aged
11
2023
7988
0.540
Why?
Female
15
2023
12740
0.540
Why?
Respiratory Tract Infections
1
2017
50
0.540
Why?
Buprenorphine
1
2016
48
0.520
Why?
Clinical Trials as Topic
3
2020
132
0.500
Why?
Time Management
1
2014
1
0.480
Why?
Operating Rooms
1
2014
3
0.480
Why?
Clinical Medicine
1
2014
3
0.470
Why?
Academic Medical Centers
1
2014
30
0.460
Why?
Aged, 80 and over
6
2023
1923
0.460
Why?
Shock, Cardiogenic
3
2022
6
0.440
Why?
Opioid-Related Disorders
1
2016
172
0.440
Why?
Renin-Angiotensin System
3
2022
17
0.430
Why?
Diabetes Mellitus, Type 2
1
2019
755
0.390
Why?
Angiotensins
2
2022
3
0.380
Why?
Natriuretic Peptide, Brain
3
2021
27
0.370
Why?
Medicare
2
2022
205
0.370
Why?
Aftercare
2
2021
49
0.350
Why?
Follow-Up Studies
5
2021
1213
0.340
Why?
Peptide Fragments
2
2021
27
0.330
Why?
Outpatients
2
2020
110
0.310
Why?
Comorbidity
2
2021
597
0.300
Why?
Chronic Disease
2
2022
428
0.290
Why?
Cohort Studies
2
2022
2586
0.260
Why?
Double-Blind Method
3
2021
155
0.240
Why?
Prospective Studies
4
2021
1279
0.240
Why?
American Heart Association
2
2022
49
0.240
Why?
Troponin T
2
2021
10
0.240
Why?
Troponin
2
2022
9
0.230
Why?
Critical Care
2
2022
71
0.230
Why?
Cause of Death
3
2019
181
0.220
Why?
Risk Factors
3
2021
3356
0.220
Why?
Time Factors
4
2021
1093
0.210
Why?
Retrospective Studies
5
2021
2461
0.210
Why?
Cardiotonic Agents
2
2020
12
0.210
Why?
Myeloproliferative Disorders
1
2022
1
0.210
Why?
Hypertension, Pulmonary
1
2022
8
0.210
Why?
Leukemia
1
2022
9
0.210
Why?
Acute Disease
2
2020
142
0.200
Why?
Patient Care Team
1
2023
113
0.200
Why?
Heart Injuries
1
2021
1
0.200
Why?
Network Meta-Analysis
1
2021
3
0.200
Why?
Drug Labeling
1
2021
14
0.190
Why?
United States Food and Drug Administration
1
2021
34
0.190
Why?
Randomized Controlled Trials as Topic
2
2020
328
0.190
Why?
Myocardium
1
2021
6
0.190
Why?
Inappropriate Prescribing
1
2021
8
0.190
Why?
Health Care Costs
2
2021
229
0.190
Why?
Troponin I
1
2021
8
0.190
Why?
Mineralocorticoid Receptor Antagonists
1
2021
10
0.190
Why?
Societies, Medical
1
2021
75
0.190
Why?
Information Dissemination
1
2021
51
0.180
Why?
Patients
1
2021
34
0.180
Why?
Sympathetic Nervous System
1
2020
3
0.180
Why?
National Library of Medicine (U.S.)
1
2020
1
0.180
Why?
Antidiuretic Hormone Receptor Antagonists
1
2020
11
0.180
Why?
Guideline Adherence
2
2021
157
0.180
Why?
Triage
1
2020
16
0.180
Why?
Heart Murmurs
1
2020
1
0.180
Why?
Tricuspid Valve Insufficiency
1
2020
3
0.180
Why?
Pneumonia
1
2021
51
0.180
Why?
Research Design
1
2023
376
0.180
Why?
Tertiary Care Centers
1
2020
4
0.180
Why?
Sensitivity and Specificity
1
2021
304
0.180
Why?
Hypoglycemic Agents
2
2020
271
0.180
Why?
Pilot Projects
1
2021
218
0.180
Why?
Dose-Response Relationship, Drug
2
2018
129
0.170
Why?
Hospitals
1
2020
80
0.170
Why?
Disease Progression
2
2021
264
0.170
Why?
Fever
1
2020
55
0.170
Why?
Hemodilution
1
2019
1
0.170
Why?
Benzazepines
1
2019
24
0.170
Why?
Sitagliptin Phosphate
1
2019
3
0.170
Why?
Asia
1
2019
15
0.170
Why?
Diuretics
1
2019
17
0.170
Why?
North America
1
2019
42
0.170
Why?
Europe
1
2019
42
0.170
Why?
Cost of Illness
1
2020
92
0.160
Why?
Kaplan-Meier Estimate
1
2019
129
0.160
Why?
Length of Stay
1
2020
181
0.160
Why?
Ambulatory Care
1
2020
247
0.150
Why?
Medication Adherence
1
2021
245
0.150
Why?
Digoxin
1
2018
12
0.150
Why?
Severity of Illness Index
2
2017
455
0.150
Why?
Quality of Life
2
2022
510
0.150
Why?
Heart Ventricles
1
2017
17
0.140
Why?
Maximum Tolerated Dose
1
2017
3
0.140
Why?
Proportional Hazards Models
1
2019
710
0.140
Why?
Emergency Service, Hospital
1
2020
368
0.140
Why?
Exercise Therapy
1
2018
71
0.140
Why?
Administration, Sublingual
1
2016
1
0.140
Why?
Injections, Subcutaneous
1
2016
4
0.140
Why?
Biopsy, Needle
1
2016
13
0.140
Why?
Risk Assessment
2
2021
1101
0.140
Why?
Immunohistochemistry
1
2016
44
0.130
Why?
Withholding Treatment
1
2016
26
0.130
Why?
Biomarkers
3
2022
303
0.130
Why?
Cost-Benefit Analysis
1
2017
250
0.130
Why?
Time and Motion Studies
1
2014
3
0.120
Why?
Systems Analysis
1
2014
5
0.120
Why?
Efficiency, Organizational
1
2014
32
0.120
Why?
Exercise
1
2018
492
0.110
Why?
Quality Improvement
1
2014
194
0.100
Why?
Adult
3
2021
7678
0.100
Why?
Survival Rate
2
2021
260
0.080
Why?
Health Status
2
2022
298
0.080
Why?
Incidence
2
2021
1266
0.070
Why?
Prognosis
2
2021
609
0.070
Why?
Nursing Homes
1
2023
8
0.050
Why?
Denmark
1
2023
18
0.050
Why?
Up-Regulation
1
2021
7
0.050
Why?
Critical Illness
1
2022
50
0.050
Why?
Natriuretic Peptides
1
2021
5
0.050
Why?
Colchicine
1
2020
1
0.050
Why?
Endpoint Determination
1
2020
10
0.050
Why?
Vasodilator Agents
1
2020
9
0.050
Why?
Intensive Care Units
1
2022
105
0.050
Why?
Extracorporeal Membrane Oxygenation
1
2020
14
0.040
Why?
Echocardiography, Transesophageal
1
2020
3
0.040
Why?
Cardiovascular Agents
1
2020
24
0.040
Why?
Statistics as Topic
1
2020
64
0.040
Why?
Fibrinolytic Agents
1
2020
44
0.040
Why?
Diagnosis, Differential
1
2020
60
0.040
Why?
Decision Making
1
2022
183
0.040
Why?
Combined Modality Therapy
1
2020
145
0.040
Why?
Predictive Value of Tests
1
2021
354
0.040
Why?
Reproducibility of Results
1
2020
381
0.040
Why?
Patient Participation
1
2020
134
0.040
Why?
Databases, Factual
1
2020
315
0.040
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2020
172
0.040
Why?
Socioeconomic Factors
1
2020
630
0.040
Why?
France
1
2018
12
0.040
Why?
Canada
1
2018
66
0.040
Why?
Systole
1
2017
22
0.040
Why?
Young Adult
1
2021
2461
0.030
Why?
Concepts (184)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
-->

© 2025 Kaiser Permanente